GRPR and prostate carcinoma: In vitro studies including cytotoxicity studies, wound-healing assay, saturation and internalization experiments were carried out in prostate cancer cell lines expressing either PSMA (LNCaP cells) or GRPr (PC3 cells), to investigate their potential future use as SPECT/MRI diagnostic tools for PCa.